Cargando…
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
We studied humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 152 long-term care facility staff and 124 residents over a prospective 4-month period shortly after the first wave of infection in England. We show that residents of long-term care facili...
Autores principales: | Tut, Gokhan, Lancaster, Tara, Butler, Megan S., Sylla, Panagiota, Spalkova, Eliska, Bone, David, Kaur, Nayandeep, Bentley, Christopher, Amin, Umayr, Jadir, Azar T., Hulme, Samuel, Ayodel, Morenike, Dowell, Alexander C., Pearce, Hayden, Zuo, Jianmin, Margielewska-Davies, Sandra, Verma, Kriti, Nicol, Samantha, Begum, Jusnara, Jinks, Elizabeth, Tut, Elif, Bruton, Rachel, Krutikov, Maria, Shrotri, Madhumita, Giddings, Rebecca, Azmi, Borscha, Fuller, Chris, Irwin-Singer, Aidan, Hayward, Andrew, Copas, Andrew, Shallcross, Laura, Moss, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154219/ https://www.ncbi.nlm.nih.gov/pubmed/37118449 http://dx.doi.org/10.1038/s43587-022-00224-w |
Ejemplares similares
-
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study
por: Tut, Gokhan, et al.
Publicado: (2022) -
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
por: Tut, Gokhan, et al.
Publicado: (2021) -
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
por: Tut, Gokhan, et al.
Publicado: (2023) -
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
por: Stirrup, Oliver, et al.
Publicado: (2022) -
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
por: Krutikov, Maria, et al.
Publicado: (2022)